Search clinical trials for: Placebo (matching empagliflozin)
Total 55215 results
-
Dong-A ST Co., Ltd.CompletedType2 DiabetesKorea, Republic of
-
AstraZenecaRecruitingLiver CirrhosisItaly, Japan, Germany, Belgium, Poland, Australia, United States, United Kingdom, Czechia, Slovakia
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Netherlands, Belgium, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
AstraZenecaRecruitingHeart Failure and Impaired Kidney FunctionSpain, France, Germany, Italy, United States, Argentina, Czechia, Vietnam, Peru, China, Philippines, Saudi Arabia, Australia, Austria, Canada, Japan, Malaysia, Poland, Taiwan, Thailand, Israel, Brazil, Finland, Greece, Mexico, United Kingdom and more
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Klinikum NürnbergRecruitingChronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisGermany, France
-
AstraZenecaRecruitingChronic Kidney DiseaseSpain, Italy, China, Vietnam, United States, Brazil, Canada, Malaysia, Poland, Taiwan, Austria, Japan, Turkey, Bulgaria, Chile, United Kingdom
-
Centro Universitario de Ciencias de la Salud, MexicoActive, not recruitingDiabetes Mellitus Type 2 Without ComplicationMexico
-
Medical University of WarsawMedical University of Graz; Medical University of Vienna; Poznan University of... and other collaboratorsRecruitingAcute Decompensated Heart FailurePoland
-
Centre Hospitalier Universitaire VaudoisUniversity College, London; Great Ormond Street Hospital for Children NHS Foundation...Not yet recruitingHeart FailureSwitzerland, United Kingdom
-
Yale UniversityBoehringer IngelheimRecruitingLiver Failure | CirrhosisUnited States
-
Hiddo Lambers HeerspinkAstraZenecaCompletedChronic Kidney Diseases | ProteinuriaCanada, Malaysia, Netherlands
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownType 2 Diabetes MellitusMexico
-
Maastricht UniversityAstraZenecaCompletedPrediabetic State | Substrate OxidationNetherlands
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Preserved Systolic FunctionUnited States
-
Assiut UniversityNot yet recruitingPerioperative Complication
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Reduced Systolic FunctionUnited States
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
October 6 UniversityUniversity of Florida; Beni-Suef University; National Heart Institute, EgyptRecruitingHeart Failure | Genetic PolymorphismsUnited States
-
National Taiwan University HospitalRecruitingVentilator Lung | Heart Failure AcuteTaiwan
-
Sohag UniversityNot yet recruiting
-
Nowarta Biopharma IncCompletedPlantar WartsUnited States
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Italy, Spain, Sweden, Canada, Bulgaria, Poland, Czechia
-
Beijing Anzhen HospitalRecruitingCoronary Artery Disease | Diabete MellitusChina
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
University of VirginiaRecruitingMyocardial IschemiaUnited States
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
AstraZenecaCompletedType 2 DiabetesUnited States, Hungary, Mexico, South Africa, Romania, Poland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
Kiyuk ChangSeoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaboratorsRecruitingMyocardial Infarction | Diabetes Mellitus, Type 2Korea, Republic of
-
Damanhour UniversityRecruitingHeart Failure | Reduced Ejection Fraction Heart FailureEgypt
-
Clinical Research Centre, MalaysiaUniversity of Malaya; Ministry of Health, MalaysiaRecruitingCoronary Artery DiseaseMalaysia
-
University Medical Centre LjubljanaUnknownDiabetes Complications | Diabetes Mellitus, Type 1 | Vascular Stiffness | Hypoglycemic AgentsSlovenia
-
University of Turin, ItalyUnknownDiabetes Mellitus, Type 2 | Body Weight Changes | Arterial HypertensionItaly
-
Ain Shams UniversityNot yet recruiting
-
Boehringer IngelheimEli Lilly and Company; Medical Research Council Population Health Research...Active, not recruitingChronic Kidney DiseaseUnited States, Canada, United Kingdom, China, Germany, Italy, Japan, Malaysia
-
China Medical University HospitalCompleted
-
Resverlogix CorpNot yet recruiting
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
Syneos HealthShanghai Novamab Biopharmaceuticals Co. Ltd.Terminated
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
Huabo Biopharm Co., Ltd.Completed
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
University Hospital TuebingenAstraZeneca; German Federal Ministry of Education and Research; German Center...RecruitingRenal Failure | PreDiabetes | Type2diabetesGermany
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedAsthma; Allergic RhinitisChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed